We recently encountered a case of hereditary spherocytosis coexisting with Gilbert's syndrome. Patient was initially diagnosed with Gilbert's syndrome and observed, but other findings suggestive of concurrent hemolysis, such as splenomegaly and gallstones were noted during the follow-up period. Therefore, further evaluations, including a peripheral blood smear, osmotic fragility test, autohemolysis test, and red blood cell membrane protein test were performed, and coexisting hereditary spherocytosis was diagnosed. Genotyping of the conjugation enzyme uridine diphosphate-glucuronosyltransferase was used to confirm Gilbert's syndrome. Because of the high prevalence rates and similar symptoms of these 2 diseases, hereditary spherocytosis can be masked in patients with Gilbert's syndrome. In review of a case and other article, the possibility of the coexistence of these 2 diseases should be considered, especially in patients with unconjugated hyperbilirubinemia who also have splenomegaly and gallstones. (Korean J Gastroenterol 2013;61:166-169) 
INTRODUCTION
Hereditary spherocytosis (HS), the most common form of inherited hemolytic anemia, is caused by a defect in one of the proteins that couples the red cell membrane skeleton to the plasma membrane. Its prevalence in Europe and North America is 1 per 2,000 persons. 1 The primary lesion in HS is the loss of membrane surface area, leading to reduced membrane deformity, due to defects in the membrane proteins ankyrin, band 3, α-spectrin, β-spectrin, or protein 4.2. 1 The clinical symptoms are variable but most often include anemia, jaundice, and splenomegaly. Most patients have well-compensated anemia but exhibit icterus and cholelithiasis due to chronic hemolysis. 2 Gilbert's syndrome (GS) is a common cause of unconjugated hyperbilirubinemia due to diminished activity of the conjugating enzyme uridine diphosphate-glucuronyl transferase (UGT1A1). The prevalence of GS is approximately 3-10% in the West and 3% in the East. 3 HS and GS can coexist, [4] [5] [6] but only one such case has been reported in Korea. 7 Herein, a case of HS combined with GS that we recently encountered is presented. Fig. 1 . Peripheral blood smear (Wright-Giemsa stain, ×1,000). Normochromic normocytic red blood cells and characteristic spherocytes (arrow) lacking central pallor, which was specific to hereditary spherocytosis. Some schistocytes were present. 
DISCUSSION
GS is the most common form of familial unconjugated hyperbilirubinemia. Plasma bilirubin concentrations are most often less than 3 mg/dL, with 2-3-fold increases commonly occurring during fasting or intercurrent illness. 8 The clinical presentation is nonspecific, but some patients experience weakness or upper abdominal discomfort. GS does not lead to hepatic damage and therefore usually requires no treatment. Decreased conjugation of bilirubin due to diminished activity of the conjugation enzyme UGT1A1 is associated with increased production of monoconjugated bilirubin. The disorder is usually due to polymorphism in a TA-repeat element, A(TA)5-8TAA, of the UGT1A1 promoter. 9 Maruo et al. 9 reported linkage of GS to A(TA)7TAA (UGT1A1 28) and
T-3279G (UGT1A1 60). An in-vitro expression study revealed that the transcriptional activity of the A (TA)7TAA allele is one-third of the normal value and that T-3279G reduces the transcriptional activity to 60% of the normal value. The prevalence of GS is usually estimated as approximately 3-10% in the West and 3% in the East. 3 The prevalence of GS in Korea specifically has not been studied but is predicted to be similar to that of other East Asian populations. 3 HS is the most common congenital hemolytic anemia in Caucasians, with an estimated prevalence of 1 in 2,000. in hypotonic solutions and lyse at a higher concentration of NaCl than do normal biconcave RBCs. 10 The autohemolysis test is also helpful to diagnose HS. The RBCs lose membrane and become more spherocytic after incubating sterile defibrinated blood at 37 o C for 48 hours. In normal blood, the amount of autohemolysis at 48 hours is 0.2-2.0% when incubated without added glucose and less than 0.9% when incubated with added glucose. 10 Autohemolysis is virtually always increased in blood from patients with HS, while the addition of glucose decreases the lysis to a variable extent. Rarely, patients with strong clinical and laboratory evidence of HS will exhibit normal incubated osmotic fragility. 10 There is no specific biological correlation between HS and GS, but the high prevalence rates of both diseases suggest that their coexistence should occur more frequently than it is actually diagnosed. The prevalence of the coexistence of HS and GS has not studied in Korea, but from the individual prevalence rates (GS, 3-10%; HS, 1 per 2,000 persons), it can be predicted almost 15-50 per million births. The diagnosis of HS with coexisting GS is complicated, and the HS is usually masked or misdiagnosed. The simultaneous presence of GS has been described as a possible cause of HS misdiagnosis. 6 The co-inheritance of GS in patients with HS is associated with a higher bilirubin level and a tendency to form gallstones almost 5-fold greater than that of normal HS patients. 11 Therefore, the possibility of the coexistence of GS and HS should be consider in GS patients who have Gallstones, because of high prevalence.
The patient in this report were initially suspected to have GS alone and were observed for some time. During follow-up, evidences of hemolysis was detected, which led to their being diagnosed with coexisting GS and HS. But the patient had splenomegaly during their initial work-ups for hyperbilirubinemia. In addition, he had a bilirubin level higher than usual for GS or HS alone, even it was checked local clinic and de- ter; therefore, close ultrasonographic follow-up is recommended. 2 However, coexisting GS increases the risk of developing gallstones 5-fold. 11 The patient who had gallstones was considered a candidate for cholecystectomy. However, there have been no specific recommendations or guidelines for this situation, and further evaluation is therefore needed.
In summary, we encountered a patient with coexisting GS and HS, initially it was considered only GS, but their splenomegaly and gallstones suggested HS. After then HS was diagnosed by a PBS, osmotic fragility test, and autohemolysis test, and the GS was confirmed by UGT1A1 genotyping.
Because of the high prevalence rates and similar symptoms of GS and HS, HS can be masked in GS patients. Therefore, the possibility of the coexistence of GS and HS should be considered, especially in patients with splenomegaly and gallstones. No treatment for patients with coexisting GS and HS has yet been established.
